Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
Vivmark Residential Common Shares of Beneficial InterestTrade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.16 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 26.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.

NUVBVMRK
Market Cap
$1.74B$46.41B
Volume
9,289,6196,584,008
Sector
HealthReal Estate
52-Week High
$9.54$70.15
52-Week Low
$3.41$57.98
Typical Hold Time
1 Days1 Days
Enterprise Value
$1.33B$55.52B
Dividend Yield
—4.68%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About Vivmark Residential Common Shares of Beneficial Interest

Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.

Read more on VMRK →